特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
356410

無菌医療包装市場における規制環境・影響分析 2020年:規格 & 規制、地域 & 国の規制団体

Regulatory Environment and Impact Analysis - Sterile Packaging Market Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis & Forecast to 2020

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 124 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
無菌医療包装市場における規制環境・影響分析 2020年:規格 & 規制、地域 & 国の規制団体
出版日: 2016年04月15日
発行: MarketsandMarkets
ページ情報: 英文 124 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の無菌医療包装市場は、2015年の265億5,000万米ドルから2020年までに350億7,000万米ドルへ達すると予測されており、この間のCAGR (複合年間成長率) は5.72% が見込まれています。

当レポートでは、世界の無菌医療包装市場を調査し、市場の概要、国際的な規制団体、地域・主要国における市場規模と主な規制団体、および主な規制などについて分析しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 無菌医療包装の市場概要

  • イントロダクション
  • 発展
  • 市場ダイナミクス
    • 促進因子
    • 抑制因子
    • 機会
    • 課題
  • 無菌医療包装の開発
  • 無菌医療包装の機能
    • 保護
    • 使いやすさ
    • 識別
    • プロセス可能性
    • 特殊用途

第5章 国際規制団体

  • イントロダクション
  • 米国試験材料協会 (ASTM)
  • 国際標準化機構 (ISO)
  • 米国食品医薬品局 (FDA)
  • 国際医療機器規制当局フォーラム (IMDRF)

第6章 北米における無菌医療包装の規制の枠組み

  • 北米
  • 北米の無菌医療包装市場規模:国別
    • 米国
    • 米国における主な規制団体
    • カナダ
    • カナダにおける主な規制団体
    • メキシコ
    • メキシコにおける主な規制団体

第7章 欧州における無菌医療包装の規制の枠組み

  • 欧州
  • 欧州の無菌医療包装市場規模:国別
  • 欧州の規制団体
    • 欧州標準化委員会 (CEN)
    • STERILE BARRIER ASSOCIATION (SBA)
  • 欧州の医療機器規制
    • イントロダクション
    • 医療機器指令 (93/42/EEC)
  • 欧州における医療機器規制の影響
    • CEマーキング:欧州市場アクセスへの入り口
    • ENとISO間の協調の影響
  • 欧州の主要国
    • ドイツ
    • ドイツにおける主な規制団体
    • 英国
    • 英国における主な規制団体
    • フランス
    • フランスにおける主な規制団体
    • イタリア
    • イタリアにおける主な規制団体

第8章 アジア太平洋における無菌医療包装の規制の枠組み

  • アジア太平洋
  • アジア太平洋の無菌医療包装市場規模:国別
    • 中国
    • 中国における主な規制団体
    • 日本
    • 日本における主な規制団体
    • インド
    • インドにおける主な規制団体
    • オーストラリア
    • オーストラリアにおける主な規制団体

第9章 その他 (ROW) 無菌医療包装の規制の枠組み

  • ROW
  • ROWの無菌医療包装市場規模:国別
    • ブラジル
    • ブラジルにおける主な規制団体
    • アルゼンチン
    • アルゼンチンにおける主な規制団体
    • 南アフリカ
    • 南アフリカにおける主な規制団体

第10章 付録

図表

目次
Product Code: PK 4234

Growing demand from the healthcare industry to drive the market for sterile medical packaging

The global market for sterile medical packaging is projected to grow from USD 26.55 billion in 2015 to reach USD 35.07 billion by 2020, at an estimated CAGR of 5.72%. The market for sterile medical packaging is driven by the growing demand from the healthcare industry due to increase in health awareness.

Need for harmonization between the global standards and regulations in the sterile medical packaging market

In line with the global applicable standards, each country may have its own specific set of applications and environments in which the product needs to perform. Having multiple standards may create confusion and trade barriers for manufacturers. Hence, in order to avoid this as well as to easily understand and implement packaging requirements, harmonization between the standards is necessary.

Asia-Pacific projected to grow during the forecast period

Asia-Pacific is projected to be the fastest-growing region in the sterile medical packaging market in the next five years. However, factors such as longer timelines for approving the medical devices in Australia, red tapism in India, and higher cost for the approval of medical devices make the regulatory framework in the region more complex.

Breakdown of Primaries:

Primary interviews were conducted with a number of industry experts in order to collect data related to different aspects of sterile medical packaging. Estimates reached after analyzing secondary sources were validated through these interviews. Primary sources include professionals such as sterile packaging manufacturers, distributors, and academic professionals. Distribution of primary interviews is as follows:

  • By Company Type: Tier 1 - 38%, Tier 2 - 38%, and Tier 3 - 24%
  • By Designation: C-level - 38%, Manager Level - 34%, and Others* - 28%
  • By Region: North America - 32%, Europe - 28%, Asia-Pacific - 25%, and RoW - 15%

The tier of the companies is defined on the basis of their total revenue, as of 2014: Tier 1: Revenue over USD 500 million, Tier 2: Revenue USD 100 to USD 500 million, and Tier 3: Revenue Less than USD 100 million.

Others include sales managers, marketing managers, and product managers.

Reasons to Buy the Report:

The report will help the market leaders/new entrants in this market in the following ways:

  • 1. This report segments the market for sterile medical packaging comprehensively and provides the closest approximations of the revenue numbers for the overall market across different regions.
  • 2. The report helps stakeholders to understand the market and related regulations further providing them information on key market drivers, restraints, challenges, and opportunities.
  • 3. The report helps to understand the regulatory aspects of the sterile medical packaging industry for the top key countries and regions.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. PERIODIZATION CONSIDERED FOR THE STERILE MEDICAL PACKAGING MARKET
  • 1.4. CURRENCY CONSIDERED FOR THE STERILE MEDICAL PACKAGING MARKET
  • 1.5. UNIT CONSIDERED FOR THE STERILE MEDICAL PACKAGING MARKET
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key Data From Secondary Sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key Data From Primary Sources
        • 2.1.2.1.1. Breakdown of primaries by company type, designation & region
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. OVERVIEW OF PARENT INDUSTRY
    • 2.2.3. DEMAND-SIDE ANALYSIS
      • 2.2.3.1. Rising Population
        • 2.2.3.1.1. Increase in the middle-class population, 2009-2030
      • 2.2.3.2. Increasing Urban population
      • 2.2.3.3. Developing Economies: GDP (Purchasing Power Parity)
    • 2.2.4. SUPPLY-SIDE ANALYSIS
      • 2.2.4.1. Fluctuation in Raw Material Prices
      • 2.2.4.2. Increasing Investment in Research & Development to Develop Innovative Technologies
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.5.1. ASSUMPTIONS
    • 2.5.2. LIMITATIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. REGULATORY SCENARIO
    • 3.2.1. REGULATORY FRAMEWORK IN NORTH AMERICA
    • 3.2.2. REGULATORY FRAMEWORK IN ASIA-PACIFIC
    • 3.2.3. REGULATORY FRAMEWORK IN EUROPE
    • 3.2.4. REGULATORY FRAMEWORK IN ROW
  • 3.3. MEDICAL DEVICE APPROVAL PROCESS IN KEY COUNTRIES
  • 3.4. IMPACT ANALYSIS
    • 3.4.1. CASE STUDY: MEDICAL DEVICE RECALL & ITS IMPACT
    • 3.4.2. NEED FOR HARMONIZATION OF GLOBAL STANDARDS & REGULATIONS

4. MARKET OVERVIEW OF STERILE MEDICAL PACKAGING

  • 4.1. INTRODUCTION
  • 4.2. EVOLUTION
  • 4.3. MARKET DYNAMICS
    • 4.3.1. DRIVERS
      • 4.3.1.1. Increased Health Awareness
      • 4.3.1.2. Growing Demand from Healthcare Industry
      • 4.3.1.3. Aging Population
    • 4.3.2. RESTRAINTS
      • 4.3.2.1. Stringent Regulations
    • 4.3.3. OPPORTUNITIES
      • 4.3.3.1. New Product Development and Continuous Innovations in Pharmaceuticals
      • 4.3.3.2. Developing New Sustainable Packaging Options
    • 4.3.4. CHALLENGES
      • 4.3.4.1. Maintaining Medical Packaging Integrity
      • 4.3.4.2. Rise in Healthcare Cost
  • 4.4. STERILE MEDICAL PACKAGE DEVELOPMENT
  • 4.5. FUNCTIONS OF A STERILE MEDICAL PACKAGE
    • 4.5.1. PROTECTION
    • 4.5.2. EASE OF USE
    • 4.5.3. IDENTIFICATION
    • 4.5.4. PROCESSABILITY
    • 4.5.5. SPECIAL APPLICATIONS

5. INTERNATIONAL GOVERNING BODIES

  • 5.1. INTRODUCTION
  • 5.2. AMERICAN SOCIETY FOR TESTING AND MATERIALS (ASTM)
    • 5.2.1. ASTM COMMITTEE D10
      • 5.2.1.1. D10.13
      • 5.2.1.2. D10.19
      • 5.2.1.3. D10.27
      • 5.2.1.4. D10.32
    • 5.2.2. ASTM COMMITTEE F02
      • 5.2.2.1. F02.10
      • 5.2.2.2. F02.15
      • 5.2.2.3. F02.20
      • 5.2.2.4. F02.40
      • 5.2.2.5. F02.50
  • 5.3. INTERNATIONAL ORGANIZATION OF STANDARDIZATION (ISO)
    • 5.3.1. DEVELOPING ISO STANDARDS
      • 5.3.1.1. Preliminary Stage
      • 5.3.1.2. Proposal Stage
      • 5.3.1.3. Preparatory Stage
      • 5.3.1.4. Committee Stage
      • 5.3.1.5. Enquiry Stage
      • 5.3.1.6. Approval Stage
      • 5.3.1.7. Publication Stage
    • 5.3.2. STANDARDS RELATED TO STERILE MEDICAL PACKAGING
      • 5.3.2.1. ISO 16775
      • 5.3.2.2. ISO 11607
        • 5.3.2.2.1. Application
        • 5.3.2.2.2. Limitation
      • 5.3.2.3. ISO 11607-1
      • 5.3.2.4. ISO 11607-2
  • 5.4. U.S. FOOD AND DRUG ADMINISTRATION (FDA)
  • 5.5. INTERNATIONAL MEDICAL DEVICE REGULATORY FORUM (IMDRF)

6. REGULATORY FRAMEWORK FOR STERILE MEDICAL PACKAGING IN NORTH AMERICA

  • 6.1. NORTH AMERICA
  • 6.2. NORTH AMERICA: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY
    • 6.2.1. U.S.
    • 6.2.2. KEY GOVERNING BODIES IN THE U.S.
      • 6.2.2.1. FDA
        • 6.2.2.1.1. Overview
        • 6.2.2.1.2. Responsibilities
    • 6.2.3. CANADA
    • 6.2.4. KEY GOVERNING BODIES IN CANADA
      • 6.2.4.1. Health Canada (HC)
        • 6.2.4.1.1. Overview
        • 6.2.4.1.2. Responsibilities
    • 6.2.5. MEXICO
    • 6.2.6. KEY GOVERNING BODIES IN MEXICO
      • 6.2.6.1. Federal Commission for the Protection Against Sanitary Risk (COFEPRIS)
        • 6.2.6.1.1. Overview
        • 6.2.6.1.2. Responsibilities

7. REGULATORY FRAMEWORK FOR STERILE MEDICAL PACKAGING IN EUROPE

  • 7.1. EUROPE
  • 7.2. EUROPE: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY
  • 7.3. GOVERNING BODIES IN EUROPE
    • 7.3.1. EUROPEAN COMMITTEE FOR STANDARDIZATION (CEN)
      • 7.3.1.1. Overview
      • 7.3.1.2. Standards Developed by CEN
        • 7.3.1.2.1. Harmonization of EN 868-1 and ISO 11607
        • 7.3.1.2.2. EN 868-2: 2009
        • 7.3.1.2.3. EN 868-3:2009
        • 7.3.1.2.4. EN 868-4:2009
        • 7.3.1.2.5. EN 868-5:2009
        • 7.3.1.2.6. EN 868-6:2009
        • 7.3.1.2.7. EN 868-7:2009
        • 7.3.1.2.8. EN 868-8:2009
        • 7.3.1.2.9. EN 868-9:2009
        • 7.3.1.2.10. EN 868-10:2009
    • 7.3.2. STERILE BARRIER ASSOCIATION (SBA)
      • 7.3.2.1. Overview
      • 7.3.2.2. SBA Member Categories
      • 7.3.2.3. Administering Activities
  • 7.4. MEDICAL DEVICE REGULATIONS IN EUROPE
    • 7.4.1. INTRODUCTION
    • 7.4.2. MEDICAL DEVICE DIRECTIVE (93/42/EEC)
  • 7.5. IMPACT OF MEDICAL DEVICE REGULATIONS IN EUROPE
    • 7.5.1. CE MARKING- A GATEWAY TO ACCESS EUROPEAN MARKET
    • 7.5.2. IMPACT OF HARMONIZATION BETWEEN EN AND ISO
  • 7.6. KEY COUNTRIES IN EUROPE
    • 7.6.1. GERMANY
    • 7.6.2. KEY GOVERNING BODIES IN GERMANY
      • 7.6.2.1. Federal Ministry of Health
        • 7.6.2.1.1. Overview
        • 7.6.2.1.2. Administering activities
      • 7.6.2.2. German Institute for Standardization (DIN)
        • 7.6.2.2.1. Overview
        • 7.6.2.2.2. Organizational structure
        • 7.6.2.2.3. Administering activities
    • 7.6.3. U.K.
    • 7.6.4. KEY GOVERNING BODIES IN THE U.K.
      • 7.6.4.1. Medicines and Healthcare products Regulatory Agency (MHRA)
        • 7.6.4.1.1. Overview
        • 7.6.4.1.2. Responsibilities
      • 7.6.4.2. Department of Health (DH)
        • 7.6.4.2.1. Overview
        • 7.6.4.2.2. Responsibilities
      • 7.6.4.3. Association of British Healthcare Industries (ABHI)
        • 7.6.4.3.1. Overview
        • 7.6.4.3.2. Responsibilities
      • 7.6.4.4. The British Standards Institution (BSI)
        • 7.6.4.4.1. Overview
        • 7.6.4.4.2. Responsibilities
    • 7.6.5. FRANCE
    • 7.6.6. KEY GOVERNING BODIES IN FRANCE
      • 7.6.6.1. National Agency for the Safety of Medicine and Health Products (ANMS)
        • 7.6.6.1.1. Overview
        • 7.6.6.1.2. Responsibilities
    • 7.6.7. ITALY
    • 7.6.8. KEY GOVERNING BODIES IN ITALY
      • 7.6.8.1. Ministry of Health (MOH)
        • 7.6.8.1.1. Overview
        • 7.6.8.1.2. Responsibilities
      • 7.6.8.2. Italian Medicines Agency
        • 7.6.8.2.1. Overview
        • 7.6.8.2.2. Responsibilities

8. REGULATORY FRAMEWORK FOR STERILE MEDICAL PACKAGING IN ASIA-PACIFIC

  • 8.1. ASIA-PACIFIC
  • 8.2. ASIA-PACIFIC: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY
    • 8.2.1. CHINA
    • 8.2.2. KEY GOVERNING BODIES IN CHINA
      • 8.2.2.1. China Food and Drug Administration (CFDA)
        • 8.2.2.1.1. Overview
        • 8.2.2.1.2. Responsibilities
    • 8.2.3. JAPAN
    • 8.2.4. KEY GOVERNING BODIES IN JAPAN
      • 8.2.4.1. Ministry of Health, Labor and Welfare (MHLW)
        • 8.2.4.1.1. Overview
        • 8.2.4.1.2. Responsibilities
    • 8.2.5. INDIA
    • 8.2.6. KEY GOVERNING BODIES IN INDIA
      • 8.2.6.1. Central Drugs Standard Control Organization (CDSCO)
        • 8.2.6.1.1. Overview
        • 8.2.6.1.2. Responsibilities
    • 8.2.7. AUSTRALIA
    • 8.2.8. KEY GOVERNING BODIES IN AUSTRALIA
      • 8.2.8.1. Therapeutic Goods Administration (TGA)
        • 8.2.8.1.1. Overview
        • 8.2.8.1.2. Responsibilities

9. REGULATORY FRAMEWORK FOR STERILE MEDICAL PACKAGING IN ROW

  • 9.1. ROW
  • 9.2. ROW: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY
    • 9.2.1. BRAZIL
    • 9.2.2. KEY GOVERNING BODIES IN BRAZIL
      • 9.2.2.1. National Health Surveillance Agency (ANVISA)
        • 9.2.2.1.1. Overview
        • 9.2.2.1.2. Responsibilities
    • 9.2.3. ARGENTINA
    • 9.2.4. KEY GOVERNING BODIES IN ARGENTINA
      • 9.2.4.1. National Administration of Drugs, Foodstuffs, and Medical Technology (ANMAT)
        • 9.2.4.1.1. Overview
        • 9.2.4.1.2. Responsibilities
    • 9.2.5. SOUTH AFRICA
    • 9.2.6. KEY GOVERNING BODIES IN SOUTH AFRICA
      • 9.2.6.1. Medicines Control Council (MCC)
        • 9.2.6.1.1. Overview
        • 9.2.6.1.2. Responsibilities

10. APPENDIX

  • 10.1. INSIGHTS OF INDUSTRY EXPERTS
  • 10.2. DISCUSSION GUIDE
  • 10.3. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 10.4. AVAILABLE CUSTOMIZATIONS
  • 10.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: ASIA-PACIFIC: URBANIZATION PROSPECTS
  • TABLE 2: TECHNICAL SUBCOMMITTEES
  • TABLE 3: TECHNICAL SUBCOMMITTEES
  • TABLE 4: ANNEX
  • TABLE 5: ISO 11607-1
  • TABLE 6: ISO 11607-2
  • TABLE 7: NORTH AMERICA: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 8: NORTH AMERICA: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS)
  • TABLE 9: EUROPE: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: EUROPE: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS)
  • TABLE 11: EN 868-2:2009
  • TABLE 12: IMPLEMENTATION OF EN 868-2:2009 IN EUROPEAN COUNTRIES
  • TABLE 13: EN 868-3:2009
  • TABLE 14: IMPLEMENTATION OF EN 868-3:2009 IN EUROPEAN COUNTRIES
  • TABLE 15: EN 868-4:2009
  • TABLE 16: IMPLEMENTATION OF EN 868-4:2009 IN EUROPEAN COUNTRIES
  • TABLE 17: EN 868-5:2009
  • TABLE 18: IMPLEMENTATION OF EN 868-5:2009 IN EUROPEAN COUNTRIES
  • TABLE 19: EN 868-6:2009
  • TABLE 20: IMPLEMENTATION OF EN 868-6:2009 IN EUROPEAN COUNTRIES
  • TABLE 21: EN 868-7:2009
  • TABLE 22: IMPLEMENTATION OF EN 868-7:2009 IN EUROPEAN COUNTRIES
  • TABLE 23: EN 868-8:2009
  • TABLE 24: IMPLEMENTATION OF EN 868-8:2009 IN EUROPEAN COUNTRIES
  • TABLE 25: EN 868-9:2009
  • TABLE 26: IMPLEMENTATION OF EN 868-9:2009 IN EUROPEAN COUNTRIES
  • TABLE 27: EN 868-10:2009
  • TABLE 28: IMPLEMENTATION OF EN 868-10:2009 IN EUROPEAN COUNTRIES
  • TABLE 29: STANDARDS PUBLISHED BY NA 063-04-04
  • TABLE 30: ASIA-PACIFIC: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: ASIA-PACIFIC: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS)
  • TABLE 32: ROW: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: ROW: STERILE MEDICAL PACKAGING MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS)

LIST OF FIGURES

  • FIGURE 1: GLOBAL POPULATION PROJECTED TO REACH ?9.5 BILLION BY 2050
  • FIGURE 2: MIDDLE-CLASS POPULATION, 2009-2030
  • FIGURE 3: PROJECTED GDP PER CAPITA, BY COUNTRY
  • FIGURE 4: FLUCTUATIONS IN PRICE OF NATURAL GAS FROM 2008 TO 2015
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: NORTH AMERICA DOMINATED THE STERILE MEDICAL PACKAGING MARKET IN 2014
  • FIGURE 8: MEDICAL DEVICES APPROVAL PROCESS IN EUROPE
  • FIGURE 9: MEDICAL DEVICES APPROVAL PROCESS IN CHINA
  • FIGURE 10: MEDICAL DEVICES APPROVAL PROCESS IN AUSTRALIA
  • FIGURE 11: PROCESS TO SUPPLY IMPORTED MEDICAL DEVICES IN AUSTRALIA
  • FIGURE 12: MEDICAL DEVICES APPROVAL PROCESS IN JAPAN
  • FIGURE 13: MEDICAL DEVICES APPROVAL PROCESS IN BRAZIL
  • FIGURE 14: REASONS FOR MEDICAL DEVICE PRODUCT RECALLS
  • FIGURE 15: EVOLUTION OF STERILE MEDICAL PACKAGING
  • FIGURE 16: STERILE MEDICAL PACKAGING MARKET DYNAMICS
  • FIGURE 17: REVENUE GENERATED BY PHARMACEUTICALS AND MEDICINES IN THE U.S.
  • FIGURE 18: GLOBAL AGING POPULATION, 2010-2015
  • FIGURE 19: NUMBER OF RECALLS, 2010-2012
  • FIGURE 20: SPENDING ON RETAIL PRESCRIPTION DRUGS
  • FIGURE 21: ISO STANDARDS PORTFOLIO, BY SECTOR, 2014
  • FIGURE 22: DEVELOPMENT PROCESS FOR ISO STANDARDS
  • FIGURE 23: MEDICAL DEVICE CIRCLE
  • FIGURE 24: MEDICAL DEVICES APPROVAL PROCESS BY FDA
  • FIGURE 25: FDA: ORGANIZATION CHART
  • FIGURE 26: HEALTH CANADA: ORGANIZATION CHART
  • FIGURE 27: FEDERAL COMMISSION FOR THE PROTECTION AGAINST SANITARY RISK: ORGANIZATION STRUCTURE
  • FIGURE 28: FEDERAL MINISTRY OF HEALTH: ORGANIZATION CHART
  • FIGURE 29: MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: ORGANIZATIONAL STRUCTURE
  • FIGURE 30: DEPARTMENT OF HEALTH: ORGANIZATION CHART
  • FIGURE 31: ASSOCIATION OF BRITISH HEALTHCARE INDUSTRIES: ORGANIZATION STRUCTURE
  • FIGURE 32: THE BRITISH STANDARDS INSTITUTION: ORGANIZATION STRUCTURE
  • FIGURE 33: NATIONAL AGENCY FOR THE SAFETY OF MEDICINE AND HEALTH PRODUCTS: ORGANIZATION CHART
  • FIGURE 34: MINISTRY OF HEALTH: ORGANIZATION STRUCTURE
  • FIGURE 35: ITALIAN MEDICINES AGENCY: ORGANIZATION CHART
  • FIGURE 36: MINISTRY OF HEALTH, LABOR AND WELFARE: ORGANIZATION STRUCTURE
  • FIGURE 37: CENTRAL DRUGS STANDARD CONTROL ORGANIZATION: ORGANIZATION STRUCTURE
  • FIGURE 38: THERAPEUTIC GOODS ADMINISTRATION: ORGANIZATION STRUCTURE
  • FIGURE 39: MEDICINES CONTROL COUNCIL: ORGANIZATION STRUCTURE "
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.